Subsequent Treatment Outcomes of Multiple Myeloma Refractory to CD38-Monoclonal Antibody Therapy
Year: 2018
Type: conference-abstract
Source: Blood
Authors: Robert Frank Cornell, Ujjawal H Gandhi, Arjun Lakshman, Zhubin Gahvari, Megan Helena Jagosky, Elizabeth McGehee, William Varnado, Ridhi Gupta, Saurabh Chhabra, Mark A. Fiala, Ehsan Malek, Joshua Mansour, Barry Paul, Alyssa Barnstead, Saranya Kodali, Amarendra K. Neppalli, Michaela Liedtke, Kelly N. Godby, Yubin Kang, Ankit Kansagra, Elvira Umyarova, Emma C. Scott, Parameswaran Hari, Ravi Vij, Saad Z. Usmani, Natalie Scott Callander, Luciano J Costa, Shaji K. Kumar
Institutions: Vanderbilt University, Vanderbilt University Medical Center, Mayo Clinic, University of Wisconsin–Madison, Levine Cancer Institute, The University of Texas Southwestern Medical Center, University of Alabama at Birmingham, Stanford Cancer Institute, Stanford University, Medical College of Wisconsin, Washington University in St. Louis, University Hospitals Seidman Cancer Center, Medical University of South Carolina, Duke University, Duke Medical Center, Oregon Health & Science University, University of Vermont, MUSC Hollings Cancer Center, Stanford Medicine, OHSU Knight Cancer Institute
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2906269269